This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (9)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Colon Cancer  • Quality of Care, Other  • Colorectal Surgery  • Surgical Oncology  • Gastrointestinal Diseases  • Alert me on articles by topic

Documenting the Process in Improving the Staging of Node-Negative Colorectal Cancer

Jan H. Wong, MD; D. Scott Johnson, MD; Daphne Hemmings, MD; Andrew Hsu, MD; Taryne Imai, BS; Gail T. Tominaga, MD

Arch Surg. 2005;140:881-887.

Hypothesis  Examination of 14 or more nodes is the optimal criterion to accurately stage node-negative colorectal cancer and predict outcome.

Design  Case series.

Setting  Three university-affiliated community medical centers.

Patients  A total of 2149 individuals with apparently localized, invasive colorectal cancer examined between January 1, 1990, and December 31, 2002.

Intervention  Study of tumor registry data.

Main Outcome Measures  Nodal status and disease-specific survival.

Results  The number of nodes examined ranged from 0 to 97 (mean ± SD, 18 ± 15 nodes). The mean number of nodes examined in node-positive individuals was 21.0 vs 16.6 in node-negative individuals (P<.001). The mean number of nodes examined at medical center A was 22.3; center B, 17.9; and center C, 14.0. The mean number of nodes examined for T3 and T4 tumors at center A was 26; center B, 20; and center C, 16 (P<.001). The node-positive rate for all T3 and T4 lesions was 49.7% at center A, 57.8% at center B, and 50.0% at center C (P<.001). Despite significant differences in the mean number of nodes examined between medical centers, the overall survival in patients with node-negative colorectal cancer in the 3 medical centers was not statistically different (P = .79). The criterion of examining 14 or more nodes distinguished between individuals at low risk for recurrence and those at increased risk.

Conclusions  Variability exists between medical centers in the pathological analysis of colorectal cancer specimens. However, within an institution, examining a mean of 14 or more nodes accurately stages apparently node-negative colorectal cancer and accurately predicts outcome.

Author Affiliations: Prevention and Control Program, Cancer Research Center of Hawaii (Dr Wong), and John A. Burns School of Medicine (Drs Wong, Johnson, Hemmings, Hsu, and Tominaga and Ms Imai), University of Hawaii at Manoa, Honolulu. Dr Johnson is now with the Department of Surgery, Martinsburg Veterans Affairs Medical Center, Martinsburg, WVa.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Lymph Node Ratio: Role in the Staging of Node-Positive Colon Cancer
Wang et al.
Ann. Surg. Oncol. 2008;15:1600-1608.
ABSTRACT | FULL TEXT  

Optimal Pathologic Staging: Defining Stage II Disease
Compton
Clin. Cancer Res. 2007;13:6862s-6870s.
ABSTRACT | FULL TEXT  

Who to treat with adjuvant therapy in Dukes B/stage II colorectal cancer? The need for high quality pathology
Morris et al.
Gut 2007;56:1419-1425.
ABSTRACT | FULL TEXT  

Accuracy of Staging Node-Negative Pancreas Cancer: A Potential Quality Measure
Tomlinson et al.
Arch Surg 2007;142:767-774.
ABSTRACT | FULL TEXT